How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Are there any issues that require special attention in light of NICE’s duties to have due regard to the need to eliminate unlawful discrimination and promote equality and foster good relations between people with a characteristic protected by the equalities legislation and others?
The content on this page is not current guidance and is only for the purposes of the consultation process.

Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis

Closed for comments This consultation ended on at   Request commenting lead permission

Draft recommendations

1.1 Evidence on the safety of pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis shows well-recognised, serious side effects. Evidence on its efficacy is inadequate in quality and quantity. Therefore, this procedure should only be used in the context of research.

1.2 Further research should report details of patient selection, including type of tumour and quality-of-life outcomes.